Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-27 @ 11:19 PM
Study NCT ID:
NCT00364793
Status:
COMPLETED
Last Update Posted:
2014-04-29
First Post:
2006-08-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02
Start Date Type:
None
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-08-15
First Submit QC Date:
None
Study First Post Date:
2006-08-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-03-06
Results First Submit QC Date:
None
Results First Post Date:
2014-04-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-04-11
Last Update Post Date:
2014-04-29
Last Update Post Date Type:
ESTIMATED